San Francisco’s STOP AIDS Project—and its locally approved, sexually explicit materials and workshops—were vindicated after a yearlong federal investigation found it “in compliance.”
India’s first matchmaker for lovelorn HIVers, Kottaram George, has founded a school in Mangalore exclusively for HIV positive pupils—who are routinely excluded from India’s public schools.
GlaxoSmithKline has axed AIDS drug prices by as much as half for HIVers in 63 of the world’s poorest countries, making good on a commitment to provide the meds at no profit.
Federal health officials warned Johns Hopkins and UCSF researchers that using terms such as men who sleep with men, sex workers, needle exchange and anal sex may endanger grant applications.
A doc in New Delhi, India, stalled surgery on an HIVer for more than five months, demanding $50,000 in special protective apparel for himself before he’d operate on a patient five hospitals had already turned away.
100,000 U.S. HIVers aren’t getting their meds, the CDC estimates, because federal and state funding for AIDS Drug Assistance Programs (ADAP) has “not kept pace with need.”